neuroClues is ISO27001:2022 certified ensuring the security of patient & hospital data
Since April 3rd 2026 neuroClues is certified ISO27001:2022 for Information Security Management Systems by AFNOR. This certification is a strong recognition of our commitment to data security, reflecti…
Prof. Dr. Lafosse and RevArte Featured in Belgian Media for Integrating neuroClues® in Neurorehabilitation
At RevArte in Edegem, clinicians are exploring how eye movements can reveal neurological disorders years before symptoms become visible. Prof. Lafosse showcasing neuroClues® device The rehabilitation …
JOIN THE ADVENTURE: Become a neuroClues Shareholder
Brussels, 27 January 2026 — Today, we at P3lab (doing business as neuroClues) are launching our crowdfunding campaign on LITA. We’re inviting you to become a shareholder of a European MedTech with the…
Concussion Assessment and Monitoring with Eye Movement Biomarkers
Clinical highlights – November 2025 neuroClues® has officially received its CE-marking as a Class IIa medical device, available for clinical use in Europe. We are excited to share insights into the po…
Instability of Neurological Diagnosis
Clinical highlights – June 2025 neuroClues® has officially received its CE-marking as a Class IIa medical device, available for clinical use in Europe. To mark Brain Awareness Month, we’re taking a cl…
Reliability of Oculomotor Biomarkers
Clinical highlights – May 2025 neuroClues® has officially received its CE-marking as a Class IIa medical device, available for clinical use in Europe. For this occasion, we have decided to highlight h…
Exploring Anti-Saccades and Frontal Lobe Function
Clinical highlights – April 2025 neuroClues has officially received its CE-marking as a Class IIa medical device, available for clinical use in Europe. For this occasion, we have decided to highlight …
Neural Pathways of Voluntary and Reflexive Saccades
Clinical highlights – March 2025 In this article, we explore the differences between voluntary and reflexive saccades, the neural pathway involved, and how they can provide interesting clues about bra…
.png)
Oculomotor Biomarkers Recorded on 50 Patients with neuroClues®, now CE-Marked!
Clinical highlights – February 2025 This month’s newsletter is eye-opening. As you may know, neuroClues® has officially received its CE-marking as a Class IIa medical device! And as if that wasn’t exc…
neuroClues secures CE certification for its eye-tracking technology set to enhance neurologic care
In summary neuroClues achieves Medical Device Regulation (MDR) certification and is now allowed to issue the CE-mark on its Class IIa medical device designed to enhance neurologic care with eye moveme…
Reference Oculomotor Ranges in Eye Tracking with NeuroClues
Clinical highlights – December 2024 For this last newsletter of 2024, we wanted to share for the first time an exclusive content about our device – neuroClues. This month, we explain how the reference…
Improving Accuracy in Pupillometry: A New Method [SfN 2024 Poster]
This poster presents a new method to improve accuracy in pupillometry, showcasing exciting advancements in pupillometry. It introduces more precise techniques for measuring pupil size and movement, wh…
Eye Movements: A Key to Supporting Pharmaceutical Research
Clinical highlights – November 2024 This month’s newsletter will highlight recent studies demonstrating how eye movements can support pharmaceutical research in diagnosing, monitoring neurological hea…
SfN 2024 eye movement research: your guide to navigating the annual meeting
Your guide to navigating the SfN 2024 annual meeting As you prepare for the SfN 2024 event, we’re here to help you make the most of this incredible experience. Whether you’re attending for the first t…
MDS 2024 Eye Movement Research: Your Guide to Navigating the Annual Meeting
Your guide to navigating the MDS 2024 annual meeting As you prepare for the MDS 2024 event, we’re here to help you make the most of this incredible experience. Whether you’re attending for the first t…
Clinical highlights: Multiple Sclerosis (MS)
Clinical highlights – August 2024 We are excited to share insights into the potential of eye tracking. Every month, we keep you updated on the latest news shared by the scientific community. The curre…
Clinical highlights: Alzheimer’s Disease (AD)
Clinical highlights – July 2024 We are thrilled to inform you about the clinical benefits of eye tracking. Every month, we keep you updated on the latest news shared by the scientific community. The c…
Clinical Get Together 2024 – Recap
Clinical Get Together 2024 - Recap Welcome to the recap of our recent scientific evening, held in conjunction with the JNLF 2024 congress. During this event, we delved into the significant contributio…
Clinical highlights: Progressive Supra Nuclear Palsy (PSP)
Clinical highlights – May 2024 We are thrilled to inform you about the clinical benefits of eye tracking. Every month, we keep you updated on the latest news shared by the scientific community. The cu…
neuroClues® secures €5 million to launch its groundbreaking technology, set to support the early diagnosis of Parkinson’s disease and other neurological disorders
neuroClues® secures €5 million to launch its groundbreaking technology, set to support the early diagnosis of Parkinson’s disease and other neurological disorders Paris, April 30, 2024 – neuroClues®, …
Clinical highlights: Automated eye tracking and a case study
Clinical highlights – March 2024 We are thrilled to inform you about the clinical benefits of eye tracking. Every once in a while, we keep you updated on the latest news shared by the scientific commu…
Clinical get together 2024
Clinical get together - Wednesday, 10th of April 2024 | 19.30 | Comet Meetings-Ternes, Paris We are pleased to invite you to our scientific evening, organized alongside the JNLF congress. Come and lis…
Poster: Evidence of an exogenous input to Superior Colliculus as a source of saccadic inhibition.
Our team presented preliminary evidence for a test that holds the potential to become a reference test in the pre-clinical diagnosis of Parkinson’s Disease. While complementary studies are required to…
SfN 2023 Eye Movement Research : Your Guide to Navigating the Annual Meeting
Your guide to navigating the SfN 2023 annal meeting Welcome to Washington DC ! As the Society for Neuroscience’s annual meeting approaches, we are excited to present a comprehensive guide to help you …
The eyes: mirrors of the soul, but above all of how our brain works. A guest opinion in ADN.
An article written by our co-founders Antoine Pouppez and Pierre Pouget, and published on ADN:
Clinical highlights: Spinocerebellar Ataxia
Clinical highlights – June 2023 We are thrilled to inform you about the clinical benefits of eye tracking. Every month, we keep you updated on the latest news shared by the scientific community. The c…
Clinical highlights: update on Parkinson’s Disease
Clinical highlights – April 2023 We are thrilled to inform you about the clinical benefits of eye tracking. Every month, we keep you updated on the latest news shared by the scientific community. The …
Clinical highlights: Alzheimer’s disease
Clinical highlights – March 2023 We are thrilled to inform you about the science of eye tracking. Every month, we will keep you updated on the latest news shared by the scientific community. The newsl…
NeuroClues™ (P3Lab) awarded funding from the European Commission through the prestigious EIC Accelerator Program - neuroClues
In summary p3lab is one of the 78 companies selected among 1092 applicants by the European program EIC Accelerator. The funds will enable the company to accelerate the go-to-market of neuroCluesTM, th…
Clinical highlights: eye tracking and concussion
Clinical highlights – October 2022 We are thrilled to inform you about the science of eye tracking. Every month, we will keep you updated on the latest news shared by the scientific community. The new…
Clinical highlights: eye tracking in Deep Brain Stimulation
Clinical highlights – September 2022 We are thrilled to inform you about the science of eye tracking. Every month, we will keep you updated on the latest news shared by the scientific community. The n…
Clinical highlights: Eye movements in Multi System Atrophy
Clinical highlights – July 2022 We are thrilled to inform you about the science of eye tracking. Every month, we will keep you updated on the latest news shared by the scientific community. The newsle…
ISO 13485:2016 certification for design & development
In summary
Eye movements in Parkinsonian syndromes
Clinical highlights – June 2022 We are thrilled to inform you about the science of eye tracking. Every month, we will keep you updated on the latest news shared by the scientific community. The newsle…
P3Lab raises 4.2 million euros
In summary P3Lab, a European startup founded in 2020 by former IBA and ICM employees is developing a medical device (NeuroClues™) based on eye tracking to support early diagnose of neurological diseas…
The beauty of studying eye movements
Practical applications Today, this wealth of scientific knowledge can be used in consultation to help the practitioners quantify their clinical examination. We list here one of many examples for each …
